Millennium Villages Project in Sub-Saharan Africa (MVP)

April 20, 2017 updated by: Sonia Sachs, Columbia University

A Pair-matched Community Intervention Trial to Assess the Impact of an Integrated Health and Development Intervention on Child Survival and the Millennium Development Goals in 10 Sub- Saharan African Countries

The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project works in partnership with governments in 10 African countries in areas where progress towards achieving the Millennium Development Goals has been insufficient.

The Project evaluation will test the following hypotheses:

  1. That after 5 years of operation, villages exposed to the MVP intervention will have a lower rate of under-5 mortality and parallel gains in MDG-related secondary outcomes when compared to similar villages not receiving the intervention.
  2. That the coordinated delivery a multi-sector package of health and development interventions implemented through a broad-based local partnership is feasible in a diversity of sub-Saharan African contexts, and;
  3. The intervention package can be delivered at a scalable cost of $40 per person per year in the health sector and $110 per person per year in total

Study Overview

Detailed Description

Design and population The design is a pair-matched community intervention trial. Village clusters with high levels of malnutrition were selected from rural areas in ten sub-Saharan African countries to reflect a diverse range of agro-ecological zones, farming systems, disease profiles, and infrastructure challenges. MVP sites represent 80 villages in 14 clusters across 10 countries, covering nearly 500,000 people. For each intervention cluster, a matched comparison cluster has been selected at random to participate in the evaluation.

Outcomes The primary outcome is the under-5 mortality rate. Secondary outcomes are levels of coverage with essential maternal-child health interventions and related MDG indicators for poverty, nutrition, education, and environmental health.

Sample size calculation The assessment follows 6000 households across intervention and matched comparison villages at baseline, and after 3 and 5 years of intervention exposure. With 10 paired clusters, the study is powered to detect a 40% difference in the U5MR between the two groups.

Analysis plan The analysis will use a two-staged pair-matched cluster level analysis, and will be complemented with multilevel modeling. Reporting will adhere to Transparent Reporting of Evaluations with Non-randomized Designs (TREND) guidelines.

Implementation science A portfolio of qualitative implementation science (process evaluation) will complement the quantitative assessment, and involves interviews with implementers, partners, and project beneficiaries. This analysis will address questions about: the feasibility of the interventions; the timing and sequence of their introduction; key contextual barriers and facilitators to implementation; and potential synergies achieved from the integrated multisector approach.

Economic costing study One project hypothesis is that an annual per capita investment of $110 is required to achieve the MDGs. The aim of the economic costing study is to document the absolute and relative contribution of project partners (MVP, government, donors, and the community) to all priced and non-priced cluster-level activities, as well as the sector-specific breakdown of these inputs.

Study Type

Interventional

Enrollment (Actual)

65000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Koraro, Ethiopia
        • Koraro
      • Bonsasso, Ghana
        • Bonsasso
      • Sauri, Kenya
        • Sauri
      • Mwandama, Malawi
        • Mwandama
      • Tiby, Mali
        • Tiby
      • Ikaram, Nigeria
        • Ikaram
      • Pampaida, Nigeria
        • Pampaida
      • Mayange, Rwanda
        • Mayange
      • Potou, Senegal
        • Potou
      • Mbola, Tanzania
        • Mbola
      • Ruhiira, Uganda
        • Ruhiira

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Resident in a Millennium Village and consenting to periodic assessments

Exclusion Criteria:

  • Those not consenting to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MVP village
Wealth stratified and randomly selected households residing in a village exposed to the Millennium Villages Project intervention (or health and development intervention package)
The timing and sequence of intervention vary by site, but include improved access to seed-fertilizer to increase agricultural production; improved market and capital access; proven maternal-newborn-child health interventions delivered free of cost at the point of service; improvements to school number and quality; and access to basic infrastructure including safe water, sanitation, electricity, transport and communication.
Other Names:
  • MVP
  • maternal-newborn-child health interventions
Active Comparator: Comparison village
Villages receiving routine services through established programs
Routine services and programs currently being administered using prevailing resources, at the current pace and with established partnerships. There is no attempt to limit the introduction of new interventions or agencies into comparison sites.
Other Names:
  • standard of care services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Mortality Rate
Time Frame: 5 years
Under 5 Mortality Rate
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Stunting
Time Frame: 5 years
Proportion of under 5s who are stunted; Stunted = low height for age Z-score
5 years
Prevalence of Diarrhea
Time Frame: 5 years
Proportion of under 5's with diarrhea in past 2 weeks
5 years
Prevalence of Malaria
Time Frame: 5 years
Prevalence of malaria among under 5s at the time of survey
5 years
Prevalence of antenatal care
Time Frame: 5 years
Proportion of women who receive at least 4 ANC visits
5 years
Survival rate to last grade of primary education (School Quality)
Time Frame: 5 years
5 years
Prevalence of improved sanitation utilization
Time Frame: 5 years
Proportion of the population using an improved sanitation source
5 years
Duration or breast feeding (Child feeding practices)
Time Frame: 5 years
5 years
Age of introduction of complementary feeding (Child feeding practices)
Time Frame: 5 years
5 years
Prevalence of bed net utilization
Time Frame: 5 years
Proportion of under 5s sleeping under Longlasting insecticide treated bednets in the night prior to the survey
5 years
Prevalence of malaria treatment
Time Frame: 5 years
Proportion of under 5s with a fever in the past 2 weeks who receive appropriate anti-malarial treatment
5 years
Prevalence of measles immunization
Time Frame: 5 years
Proportion under 1s immunized against measles
5 years
Prevalence of diarrhea management
Time Frame: 5 years
Proportion of under 5s with diarrhea in the past 2 weeks who received oral rehydration therapy
5 years
Prevalence of pneumonia management
Time Frame: 5 years
Proportion of under 5s treated for pneumonia in the past 2 weeks
5 years
Prevalence of newborn care
Time Frame: 5 years
Proportion of newborns receiving a post-natal check in the first week of life
5 years
Proportion of pregnant women who received and HIV test
Time Frame: 5 years
This measures the prevention of vertical transmission of HIV
5 years
Prevalence of food insecurity
Time Frame: 5 years
Proportion of households reporting not enough food for 1 of past 12 months
5 years
Institutional delivery rate
Time Frame: 5 years
Proportion of births attended by skilled health personnel
5 years
Prevalence of underweight
Time Frame: 5 years
Proportion of under 5s who are underweight; Underweight= weight for age Z score
5 years
Prevalence of wasting
Time Frame: 5 years
Proportion of under 5s who are wasted; Wasting = weight for height Z score
5 years
Prevalence of low mid-upper arm circumference
Time Frame: 5 years
Proportion of under 5s with a low mid-upper arm circumference
5 years
Household Asset Index (Household poverty)
Time Frame: 5 years
Survey of fixed and non-fixed assets, including recent purchases
5 years
Prevalence of improved water source utilization
Time Frame: 5 years
Proportion of the population using an improved drinking water source
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jeffrey Sachs, PhD, The Earth Institute, Columbia University
  • Study Director: Pedro Sanchez, PhD, The Earth Institute, Columbia University
  • Principal Investigator: Cheryl Palm, PhD, The Earth Institute, Columbia University
  • Principal Investigator: Sonia Sachs, MD, PhD, Director of Health, The Earth Institute, Columbia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2005

Primary Completion (Actual)

June 25, 2016

Study Completion (Actual)

June 25, 2016

Study Registration Dates

First Submitted

May 12, 2010

First Submitted That Met QC Criteria

May 17, 2010

First Posted (Estimate)

May 18, 2010

Study Record Updates

Last Update Posted (Actual)

April 21, 2017

Last Update Submitted That Met QC Criteria

April 20, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Survival

Clinical Trials on Health and development intervention package

3
Subscribe